LDL Test Market Dynamics:
The global LDL test market is projected to grow at a CAGR of ~ 5.5 % during the forecast period 2017-2023. LDL is referred as low-density lipoprotein, which is type of cholesterol found in body. Low-density lipoprotein (LDL), often known as bad cholesterol, is a microscopic blob made up of an outer rim of lipoprotein and a cholesterol center. It’s bad because it becomes part of plaque, and that can clog arteries and make heart attacks and strokes more likely. The major driving factor for the market are increasing prevalence of obesity, deskbound lifestyle and lack of exercise. According to OMICS International, atherosclerosis account for 32% of total deaths in the world, out of which, 13.8% prevalence is among adults of 20 years and above. The cases of heart failure were estimated about 30% across the globe. Coronary heart disease mortality rate was about 60% in 2010. In addition to this, increasing healthcare expenditure, increasing awareness among the people and government initiatives for research and development have fuelled the market growth.
Avail Premium Sample copy @ https://www.marketresearchfuture.com/sample_request/4215 .
Some of key players profiled in the report are Quest Diagnostics Incorporated, Sekisui Diagnostics, Express Biotech International, Randox Laboratories Ltd, Reckon Diagnostics, DiaSys Diagnostics India Private Limited, F. Hoffmann-La Roche Ltd and others..
The global LDL test market has been segmented on the basis of types, components, applications and end users.
Based on types, the market has been segmented into LDL-C, LDL-P, LDL-B and others.
Based on components, the market has been segmented into devices, kits & reagents and others. Devices is further sub-segmented into syringes & needles, spectrophotometers and others. And kits & reagents is further sub-segmented into toxicity assays kit, blood chemistry assays kit, cytotoxicity assays kit.
Based on application, the market has been segmented as atherosclerosis, obesity, dyslipidemia, diabetes, angina, stroke, carotid artery disease, peripheral arterial disease, others.
Based on the end users, the market has been segmented as hospitals and clinics, pharmaceutical and biotechnological companies and others.
The Americas account for a significant market share owing to the presence of huge number of people suffering from obesity and overweight. According to the Centers for Disease Control and Prevention (2014), 73.5 million adults in the US have diagnosed with high cholesterol level. Additionally, increasing awareness among the people regarding different monitoring procedures and well developed technology has also contributed in the growth of the market.
Europe is the second largest market in the world due to high income and encouragement by government in research and development.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.
Avail Illustrious Discount @ https://www.marketresearchfuture.com/check-discount/4215 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar